Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-26

Clinical Trial Update: The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

View source ↗

Summary

Clinical trial IMPACT studies genetic predisposition to prostate cancer in men; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Prostate Cancer, BRCA Mutation | Status: ACTIVE_NOT_RECRUITING